🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Autism Impact Fund closes $60 million first fund and broadens its scope

TechCrunchTechCrunch · 2y ago
Autism Impact Fund closes $60 million first fund and broadens its scope
Medial

Autism Impact Fund (AIF), a venture capital fund focused on investing in startups that address autism spectrum disorder (ASD) and related conditions, recently closed its first fund at $60 million, surpassing its initial target of $50 million. AIF, led by co-founder and managing partner Chris Male, aims to revolutionize the status quo for autism through the venture capital model while delivering strong returns. The fund has already made investments in 12 startups in the neurodiversity space and plans to raise its second fund within the next six to nine months. AIF's portfolio includes companies in the life sciences, data- and tech-enabled services, and the fund will further expand its focus to include behavioral health, innovative healthcare solutions, and value-based care frameworks.

Related News

Somerset Indus Capital Partners closes Fund III at $288 Mn

EntrackrEntrackr · 10d ago
Somerset Indus Capital Partners closes Fund III at $288 Mn
Medial

Somerset Indus Capital Partners today announced the successful fundraise of its third fund, Fund III, at $288 million, exceeding its initial target of $250 million. Fund III witnessed robust participation from a diverse group of global institutional investors, including development finance institutions (DFIs), global investment firms, domestic financial institutions, insurance companies, funds of funds, family offices, and impact investors across Europe, the United States, and Southeast Asia. With Fund III, Somerset will continue to focus on addressing healthcare access gaps across India’s “missing middle,” particularly in Tier II and Tier III markets. The fund will invest in scalable healthcare businesses delivering affordable and accessible quality care across healthcare delivery, pharmaceuticals, medical devices, diagnostics, and allied sectors. Somerset typically invests between $15 million and $40 million per portfolio company. However, through co-investment syndication alongside its LP network, the firm has the flexibility to participate in significantly larger transactions in the range of $60–80 million. The additional capital will enable it to support larger and more structurally transformative opportunities across areas such as preventive care and OPD-linked insurance, healthcare financing, embedded insurance solutions, value-driven generics, India-focused MedTech innovation, and diagnostics platforms improving accessibility and standardisation beyond metro markets. Through Fund III, Somerset has already made three investments, including Cyrix Healthcare, Printmann Offset, and NU Hospitals. The firm claims that its earlier funds have delivered strong performance, with Fund I generating approximately 4.0x DPI, while Fund II is advancing toward exits, with its first realisation completed in September 2025 at approximately 4x MOIC.

ChrysCapital closes $2.2 Bn Fund X

EntrackrEntrackr · 4m ago
ChrysCapital closes $2.2 Bn Fund X
Medial

ChrysCapital has closed Fund X at $2.2 billion, the largest private equity fund raised by an India-focused firm. Fund X is a 60% increase from Fund IX of $1.35 billion, closed in 2022. The firm plans to invest the capital in established companies across consumer, healthcare, financial services, enterprise technology, and industrial sectors. ChrysCapital has now raised around $8.5 billion across ten private equity funds, a continuation vehicle, and a public markets fund since 1999. It has deployed over $5.5 billion across 110 portfolio companies and realised $7.8 billion across 80 exits with a reported 3.0x ROI. Its past investments include Intas Pharmaceuticals, Mankind Pharma, GeBBS Healthcare, Infogain, NSE, and Awfis. Fund X added over 30 new global investors, including pension funds, insurers, asset managers, and family offices from Japan, the Middle East, Southeast Asia, Europe, and the US. For the first time, ChrysCapital also raised capital from Indian institutional investors and large family offices. The fund reached its final close within six months of its first close. The firm plans to deploy Fund X over the next 3–4 years and has several transactions in progress. The strategy continues to focus on majority and minority investments in businesses with strong governance, clear growth levers, and defined exit visibility. ChrysCapital competes with PE firms active in India such as TPG, Bain Capital, KKR, Blackstone, Carlyle, Warburg Pincus, and Multiples.

Download the medial app to read full posts, comements and news.